Monday Jan 23 | Freshnews
Baxter to Initiate Second Phase III Trial Studying Gammagard Liquid...
Baxter International Inc. today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10% [Immune Globulin Infusion ] , for the treatment of mild to moderate Alzheimer's disease.
Octapharma USA hires former Baxter Bioscience executive
Octapharma USA, the U.S. subsidiary of Swiss drug maker Octapharma AG, said Holliday will be responsible for U.S. product marketing, sales, commercial activities and coordination with global portfolio development initiatives.
Also on Topix